October 11, 2010

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

October 11, 2010

McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics....

October 7, 2010

The board of directors of Genzyme again has rejected a buyout offer by French drug...

October 7, 2010

The drug industry is undergoing a major paradigm shift. Companies that traditionally have relied on...

October 7, 2010

Swiss drug maker Roche has bought the rights to an investigative treatment for hepatitis C,...

October 6, 2010

The global pharmaceutical market will reach a value of $880 billion next year, according to...

October 5, 2010

AstraZeneca will provide medications free of charge to qualifying patients in Sacramento, Calif., through its...

October 5, 2010

Pfizer on Wednesday announced the completion of its acquisition of a privately held drug discovery...

October 4, 2010

Eye care company Alcon has appointed a new executive....

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

October 4, 2010

Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...

October 4, 2010

Generic drug maker Watson Pharmaceuticals is seeking approval for a generic treatment for Parkinson’s disease,...

October 3, 2010

The Food and Drug Administration turned down a regulatory approval application from Johnson & Johnson...

September 30, 2010

McNeil products soon will repopulate shelves, Johnson & Johnson chairman and CEO Bill Weldon shared...

September 30, 2010

Mylan has launched a generic version of a common antidepressant, the company said Friday....

September 30, 2010

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

September 29, 2010

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made...

September 29, 2010

Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 29, 2010

Teva Pharmaceutical Industries and OncoGenex Pharmaceuticals have started a late-stage clinical trial of an investigative...

September 29, 2010

Walgreens announced Thursday that Jeffrey Berkowitz, a former SVP at drug maker Merck, has joined...

September 28, 2010

Sun Pharmaceutical Industries' subsequent offering period by one of its subsidiaries for all outstanding ordinary...

September 27, 2010

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 27, 2010

The Food and Drug Administration has approved a generic version of a drug for a...